Inretio Medical Device

Israel
Nir‘am, Southern District, Israel

Company profile

Inretio Medical Device company profile

Inretio is a startup in the medical device industry that aims to enhance the treatment of ischemic strokes caused by blood clots blocking blood flow to the brain. Annually, over 175,000 patients in the US undergo mechanical thrombectomy, but existing devices have low success rates and high rates of disability and mortality. Inretio is working on a new solution for clot retrieval during thrombectomy that aims to minimize complications and improve outcomes for stroke patients. The PREVA clot retriever is the only device that offers protective clot retrieval using a distal basket, providing access to clots in remote areas. The device uses a PREVA basket to encapsulate and remove the clot, safeguarding the brain from sub-clots during mechanical thrombectomy. This results in, potentially, the complete removal of the clot and fragments, ensuring the full restoration of blood flow to the brain.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2020-01-01, Year

Headquarters

Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$2.5M
Last funding
Series A / $2.5M / 2022-07-01
Last equity funding
Series A / $2.5M
Founders
1
Articles
1

Founders and investors

Founders

Raviv Vine